The World Health Organization (WHO) and the Public Library of Science (PLoS) are launching a new initiative to support the latest WHO World Health Report by encouraging authors to submit articles that substantiate the WHO's message, that research is essential for better

Last week leaders in global health and tropical medicine convened in Philadelphia to talk about the latest scientific advances in their field as well as the current status of efforts to control tropica

2012 Albert B. Sabin Gold Medal Award Call for Nominations

November 30, 2011

The Sabin Vaccine Institute is honored to invite you to nominate a distinguished colleague for the 2012 Albert B. Sabin Gold Medal Award.

How to Nominate Your Distinguished Colleague

In order to nominate your colleague for the Gold Medal Award, provide a one-page explanation of the nominee’s most important vaccine research or advocacy contributions and why you believe they are particularly important. Please submit your nomination no later than Friday, December 16, 2011 to the following address:

This is the fourth post in a blog mini-series from the Dengue Vaccine Initiativeabout the collaborative work being done to ensure future access to dengue vaccines in developing nations.

Financing research and development (R&D) for neglected tropical disease (NTDs) is a big challenge. The problem? Market failure.

This is the second post in a blog mini-series from the Dengue Vaccine Initiative about the collaborative work being done to ensure future access to dengue vaccines in developing nations.

This article, written by Dr. Peter Hotez, president of Sabin Vaccine Institute and dean of the National School of Tropical Medicine at Baylor College of Medicine, originally appeared in TAMEST (The Academy of Medicine, Engineering and Science of Texas) e-news.

The Coalition against Typhoid fills a critical gap between research and action.

Great news in the world of global health! A recent clinical trial for an experimental malaria vaccine has yielded successful results in protecting a large number of children against malaria with minimal side effects.

Pages

Subscribe to RSS - Sabin Vaccine Development